These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 22536580
21. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group. Wencker M, Banik N, Buhl R, Seidel R, Konietzko N. Eur Respir J; 1998 Feb; 11(2):428-33. PubMed ID: 9551749 [Abstract] [Full Text] [Related]
22. α-1 Antitrypsin Genotype-Phenotype Discrepancy in a 42-Year-Old Man Who Carries the Null-Allele. Pavičić T, Ćelap I, Njegovan M, Tešija Kuna A, Štefanović M. Lab Med; 2020 May 06; 51(3):301-305. PubMed ID: 31583408 [Abstract] [Full Text] [Related]
23. Alpha-1 Antitrypsin Deficiency: Current Perspective from Genetics to Diagnosis and Therapeutic Approaches. Santangelo S, Scarlata S, Poeta ML, Bialas AJ, Paone G, Incalzi RA. Curr Med Chem; 2017 May 06; 24(1):65-90. PubMed ID: 27855621 [Abstract] [Full Text] [Related]
24. NullCanada: A novel α1-antitrypsin allele with in cis variants Glu366Lys and Ile100Asn. Chen S, DeMarco ML, Estey MP, Kyle B, Parker ML, Agbor TA, Kawada P, Speevak M, Nelson TN, Mattman A. Clin Biochem; 2020 May 06; 79():23-27. PubMed ID: 32087139 [Abstract] [Full Text] [Related]
25. Therapy with plasma purified alpha1-antitrypsin (Prolastin®) induces time-dependent changes in plasma levels of MMP-9 and MPO. Koepke J, Dresel M, Schmid S, Greulich T, Beutel B, Schmeck B, Vogelmeier CF, Janciauskiene S, Koczulla AR. PLoS One; 2015 May 06; 10(1):e0117497. PubMed ID: 25635861 [Abstract] [Full Text] [Related]
32. Elevated soluble HLA II protein levels in patients with alpha-1 antitrypsin deficiency with or without COPD. Li L, Kueppers F, Hildebrand W, Buchli R, Gaughan J. Exp Lung Res; 2012 Aug 06; 38(6):302-6. PubMed ID: 22686467 [Abstract] [Full Text] [Related]
34. Deletion of Serpina1a, a murine α1-antitrypsin ortholog, results in embryonic lethality. Wang D, Wang W, Dawkins P, Paterson T, Kalsheker N, Sallenave JM, Houghton AM. Exp Lung Res; 2011 Jun 06; 37(5):291-300. PubMed ID: 21574874 [Abstract] [Full Text] [Related]
35. Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis. Campos MA, Runken MC, Davis AM, Johnson MP, Stone GA, Buikema AR. Adv Ther; 2018 Apr 06; 35(4):467-481. PubMed ID: 29616482 [Abstract] [Full Text] [Related]
39. Lessons from the Past: Some Histories of Alpha-1 Antitrypsin Deficiency Before Its Discovery. Perciaccante A, Charlier P, Negri C, Coralli A, Appenzeller O, Bianucci R. COPD; 2018 Feb 06; 15(1):1-3. PubMed ID: 29469675 [Abstract] [Full Text] [Related]